These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 1845826)

  • 1. Japanese encephalitis virus-vaccinia recombinants produce particulate forms of the structural membrane proteins and induce high levels of protection against lethal JEV infection.
    Mason PW; Pincus S; Fournier MJ; Mason TL; Shope RE; Paoletti E
    Virology; 1991 Jan; 180(1):294-305. PubMed ID: 1845826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double-subgenomic Sindbis virus recombinants expressing immunogenic proteins of Japanese encephalitis virus induce significant protection in mice against lethal JEV infection.
    Pugachev KV; Mason PW; Shope RE; Frey TK
    Virology; 1995 Oct; 212(2):587-94. PubMed ID: 7571428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of protective immunity in animals vaccinated with recombinant vaccinia viruses that express PreM and E glycoproteins of Japanese encephalitis virus.
    Yasuda A; Kimura-Kuroda J; Ogimoto M; Miyamoto M; Sata T; Sato T; Takamura C; Kurata T; Kojima A; Yasui K
    J Virol; 1990 Jun; 64(6):2788-95. PubMed ID: 2159544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of protective immunity elicited by recombinant vaccinia viruses that synthesize E or NS1 of Japanese encephalitis virus.
    Konishi E; Pincus S; Fonseca BA; Shope RE; Paoletti E; Mason PW
    Virology; 1991 Nov; 185(1):401-10. PubMed ID: 1833876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased immunogenicity and protective efficacy in outbred and inbred mice by strategic carboxyl-terminal truncation of Japanese encephalitis virus envelope glycoprotein.
    Jan LR; Yang CS; Henchal LS; Sumiyoshi H; Summers PL; Dubois DR; Lai CJ
    Am J Trop Med Hyg; 1993 Mar; 48(3):412-23. PubMed ID: 8385887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection of mice against lethal Japanese encephalitis with a recombinant baculovirus vaccine.
    McCown J; Cochran M; Putnak R; Feighny R; Burrous J; Henchal E; Hoke C
    Am J Trop Med Hyg; 1990 May; 42(5):491-9. PubMed ID: 2160199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A highly attenuated host range-restricted vaccinia virus strain, NYVAC, encoding the prM, E, and NS1 genes of Japanese encephalitis virus prevents JEV viremia in swine.
    Konishi E; Pincus S; Paoletti E; Laegreid WW; Shope RE; Mason PW
    Virology; 1992 Sep; 190(1):454-8. PubMed ID: 1326813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant, chimaeric live, attenuated vaccine (ChimeriVax) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-human primates.
    Monath TP; Soike K; Levenbook I; Zhang ZX; Arroyo J; Delagrave S; Myers G; Barrett AD; Shope RE; Ratterree M; Chambers TJ; Guirakhoo F
    Vaccine; 1999 Apr; 17(15-16):1869-82. PubMed ID: 10217584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA immunization with Japanese encephalitis virus nonstructural protein NS1 elicits protective immunity in mice.
    Lin YL; Chen LK; Liao CL; Yeh CT; Ma SH; Chen JL; Huang YL; Chen SS; Chiang HY
    J Virol; 1998 Jan; 72(1):191-200. PubMed ID: 9420215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies generated by immunization with the NS1 protein of West Nile virus confer partial protection against lethal Japanese encephalitis virus challenge.
    Sun E; Zhao J; TaoYang ; Xu Q; Qin Y; Wang W; Wei P; Wu D
    Vet Microbiol; 2013 Sep; 166(1-2):145-53. PubMed ID: 23834965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant vaccinia viruses co-expressing dengue-1 glycoproteins prM and E induce neutralizing antibodies in mice.
    Fonseca BA; Pincus S; Shope RE; Paoletti E; Mason PW
    Vaccine; 1994; 12(3):279-85. PubMed ID: 8165861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The C Terminus of the Core β-Ladder Domain in Japanese Encephalitis Virus Nonstructural Protein 1 Is Flexible for Accommodation of Heterologous Epitope Fusion.
    Yen LC; Liao JT; Lee HJ; Chou WY; Chen CW; Lin YL; Liao CL
    J Virol; 2016 Feb; 90(3):1178-89. PubMed ID: 26559836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction and Immunogenicity of Recombinant Vaccinia Virus Vaccine Against Japanese Encephalitis and Chikungunya Viruses Infection in Mice.
    Zhang Y; Han JC; Jing J; Liu H; Zhang H; Li ZH; Jin NY; Lu HJ
    Vector Borne Zoonotic Dis; 2020 Oct; 20(10):788-796. PubMed ID: 32584657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant vaccinia virus producing the prM and E proteins of yellow fever virus protects mice from lethal yellow fever encephalitis.
    Pincus S; Mason PW; Konishi E; Fonseca BA; Shope RE; Rice CM; Paoletti E
    Virology; 1992 Mar; 187(1):290-7. PubMed ID: 1736531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunization with recombinant vaccinia viruses expressing structural and part of the nonstructural region of tick-borne encephalitis virus cDNA protect mice against lethal encephalitis.
    Dmitriev IP; Khromykh AA; Ignatyev GM; Gainullina MN; Ageenko VA; Dryga SA; Vorobyeva MS; Sandakhchiev LS
    J Biotechnol; 1996 Jan; 44(1-3):97-103. PubMed ID: 8717392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poxvirus-based Japanese encephalitis vaccine candidates induce JE virus-specific CD8+ cytotoxic T lymphocytes in mice.
    Konishi E; Kurane I; Mason PW; Shope RE; Ennis FA
    Virology; 1997 Jan; 227(2):353-60. PubMed ID: 9018134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective immunity to Japanese encephalitis virus associated with anti-NS1 antibodies in a mouse model.
    Li Y; Counor D; Lu P; Duong V; Yu Y; Deubel V
    Virol J; 2012 Jul; 9():135. PubMed ID: 22828206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening of protective antigens of Japanese encephalitis virus by DNA immunization: a comparative study with conventional viral vaccines.
    Chen HW; Pan CH; Liau MY; Jou R; Tsai CJ; Wu HJ; Lin YL; Tao MH
    J Virol; 1999 Dec; 73(12):10137-45. PubMed ID: 10559329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective efficacy of a plasmid DNA encoding Japanese encephalitis virus envelope protein fused to tissue plasminogen activator signal sequences: studies in a murine intracerebral virus challenge model.
    Ashok MS; Rangarajan PN
    Vaccine; 2002 Feb; 20(11-12):1563-70. PubMed ID: 11858863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mice immunized with a subviral particle containing the Japanese encephalitis virus prM/M and E proteins are protected from lethal JEV infection.
    Konishi E; Pincus S; Paoletti E; Shope RE; Burrage T; Mason PW
    Virology; 1992 Jun; 188(2):714-20. PubMed ID: 1585642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.